Hossein Shenasa, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 6 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Good Samaritan Hospital · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
26 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shenasa’s office at (408) 918-0400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A53756 · Current
Licensed to practise in California · since 1994 · expires 2028-02-29 · National University of Iran Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,449,382
Medicare paid this office $1,449,382 for 785 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 385 | $378,077 | $929 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 211 | $345,607 | $1,615 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 211 | $179,580 | $420 |
| Return visit (30+ min) | 688 | $154,360 | $120 |
| Insertion of heart rhythm monitor under skin | 19 | $94,652 | $4,733 |
See all 25 services
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 385 | $378,077 | $929 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 211 | $345,607 | $1,615 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 211 | $179,580 | $420 |
| Return visit (30+ min) | 688 | $154,360 | $120 |
| Insertion of heart rhythm monitor under skin | 19 | $94,652 | $4,733 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 55 | $56,078 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | $49,578 | $196 |
| Long return visit (40+ min) | 153 | $35,299 | $167 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 302 | $24,594 | $72 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 737 | $21,263 | $14 |
| Programming of dual lead pacemaker system | 85 | $13,119 | $78 |
| New patient visit (45+ min) | 88 | $12,389 | $141 |
| Evaluation of implantable heart and blood vessel monitoring system | 103 | $9,954 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 385 | $9,006 | $22 |
| Injection of drug or substance into vein | 212 | $8,614 | $40 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $6,988 | $159 |
| Injection, regadenoson, 0.1 mg | 209 | $4,875 | None |
| New patient visit (60+ min) | 20 | $4,099 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,800 | $109 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 21 | $1,537 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 23 | $1,532 | $24 |
| Programming of heart rhythm stimulation after drug infusion | 12 | $805 | $62 |
| Test for exercise-induced lung stress | 16 | $511 | $32 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $226 | $11 |
| Infusion, normal saline solution, 250 cc | 212 | $106 | None |
Procedures Medicare counted
| Pacemaker insertion or repair | 29 | More than 78% of doctors who do this |
Who their Medicare patients are
785 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 25% · Women 52% · Also on Medicaid 37% · Health risk score 1.43. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Atrial fibrillation 46% · Diabetes 41% · Chronic kidney disease 28% · Heart failure 20% · Cancer 16% · Depression 16% · Stroke 14% · COPD 13% · Dementia 12%.
The office billed $2,906,270, Medicare allowed $1,819,887 and paid $1,449,382; for 7,954 services of 59 kinds; $5,046 of it was for drugs given in the office and $1,444,336 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 785 | 7,954 | 78 | 1.43 | $2,906,270 | $1,449,382 |
| 2023 | 780 | 13,767 | 78 | 1.46 | $2,645,029 | $1,283,801 |
| 2022 | 772 | 17,315 | 79 | 1.45 | $2,560,979 | $1,250,304 |
| 2021 | 742 | 17,388 | 79 | 1.42 | $2,455,951 | $1,230,062 |
| 2020 | 709 | 13,468 | 78 | 1.60 | $1,911,789 | $904,452 |
| 2019 | 847 | 24,249 | 79 | 1.74 | $2,609,267 | $1,175,205 |
| 2018 | 793 | 20,956 | 79 | 1.86 | $2,387,784 | $1,029,734 |
| 2017 | 736 | 5,492 | 78 | 1.84 | $1,093,729 | $430,233 |
| 2016 | 648 | 6,708 | 79 | 1.75 | $734,672 | $262,778 |
| 2015 | 646 | 3,518 | 79 | 1.71 | $745,557 | $295,632 |
| 2014 | 694 | 4,169 | 78 | 1.60 | $751,500 | $303,727 |
| 2013 | 701 | 4,155 | 78 | 1.64 | $748,544 | $305,569 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 33 services
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 370 | $353,471 | $904 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 214 | $327,485 | $1,530 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 214 | $170,591 | $397 |
| Return visit (30+ min) | 629 | $117,390 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $36,336 | $195 |
| Long return visit (40+ min) | 172 | $36,058 | $158 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 66 | $22,844 | $38 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 286 | $21,550 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 720 | $18,256 | $13 |
| New patient visit (45+ min) | 118 | $15,549 | $132 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 66 | $13,013 | $22 |
| Programming of dual lead pacemaker system | 84 | $11,834 | $77 |
| Injection, regadenoson, 0.1 mg | 73 | $9,932 | None |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $9,432 | $786 |
| Evaluation of implantable heart and blood vessel monitoring system | 105 | $9,205 | $45 |
| Injection of drug or substance into vein | 213 | $8,232 | $38 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 370 | $8,202 | $21 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $6,389 | $152 |
| Insertion of permanent leadless pacemaker using imaging guidance | 17 | $6,346 | $373 |
| Electronic analysis of pacemaker to correct rapid heart rate | 19 | $4,017 | $211 |
| New patient visit (60+ min) | 16 | $3,220 | $201 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,132 | $104 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 142 | $2,403 | None |
| Programming of heart rhythm stimulation after drug infusion | 24 | $1,825 | $76 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,209 | $93 |
| Short return visit (20+ min) | 14 | $1,183 | $85 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 25 | $901 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 21 | $759 | $24 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 11 | $469 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $365 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $203 | $16 |
| Infusion, normal saline solution, 250 cc | 215 | $104 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $35 | $3 |
2022: 30 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 235 | $360,601 | $1,528 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 291 | $284,846 | $956 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 235 | $187,059 | $396 |
| Return visit (30+ min) | 651 | $123,125 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 245 | $48,486 | $196 |
| Long return visit (40+ min) | 186 | $38,450 | $160 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 308 | $23,628 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 725 | $19,173 | $13 |
| New patient visit (45+ min) | 133 | $18,406 | $138 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 80 | $16,798 | $24 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 80 | $15,552 | $22 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 16 | $14,886 | $930 |
| Programming of dual lead pacemaker system | 85 | $13,610 | $79 |
| Evaluation of implantable heart and blood vessel monitoring system | 122 | $12,374 | $47 |
| Injection of drug or substance into vein | 235 | $9,540 | $40 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,796 | $172 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $7,600 | $691 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 291 | $6,455 | $22 |
| Programming of multiple lead implantable defibrillator system | 15 | $4,145 | $106 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 221 | $3,399 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,944 | $89 |
| Programming of heart rhythm stimulation after drug infusion | 22 | $2,133 | $97 |
| Insertion of heart rhythm monitor under skin | 27 | $2,002 | $74 |
| Injection, regadenoson, 0.1 mg | 13 | $1,544 | None |
| Programming of single lead pacemaker system | 15 | $1,534 | $67 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $634 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 19 | $596 | $24 |
| Removal of heart rhythm monitor from under the skin | 12 | $439 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $402 | $11 |
| Infusion, normal saline solution, 250 cc | 235 | $118 | None |
2021: 28 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 243 | $394,805 | $1,625 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 243 | $201,860 | $415 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 249 | $198,427 | $781 |
| Return visit (30+ min) | 648 | $156,009 | $116 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 256 | $56,759 | $210 |
| Long return visit (40+ min) | 168 | $36,986 | $170 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 312 | $23,862 | $71 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 75 | $15,966 | $25 |
| New patient visit (45+ min) | 100 | $15,310 | $153 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 584 | $15,191 | $14 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 75 | $14,844 | $23 |
| Programming of dual lead pacemaker system | 93 | $14,773 | $78 |
| Evaluation of implantable heart and blood vessel monitoring system | 126 | $12,409 | $45 |
| Injection of drug or substance into vein | 242 | $10,695 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,982 | $181 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 254 | $5,877 | $23 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 234 | $4,661 | None |
| Electronic analysis of pacemaker to correct rapid heart rate | 16 | $3,596 | $225 |
| Programming of multiple lead implantable defibrillator system | 12 | $3,118 | $104 |
| Programming of dual lead implantable defibrillator system | 14 | $2,946 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,343 | $94 |
| Short return visit (20+ min) | 15 | $1,474 | $87 |
| Insertion of heart rhythm monitor under skin | 14 | $1,095 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 32 | $1,010 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 23 | $704 | $25 |
| Test for exercise-induced lung stress | 16 | $524 | $31 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $192 | $11 |
| Infusion, normal saline solution, 250 cc | 244 | $134 | None |
2020: 33 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 147 | $247,768 | $1,674 |
| Return visit (30+ min) | 609 | $147,063 | $101 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 147 | $124,513 | $421 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 129 | $104,452 | $791 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 244 | $53,726 | $213 |
| Long return visit (40+ min) | 153 | $28,095 | $136 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 214 | $16,457 | $72 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 74 | $14,924 | $25 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 74 | $14,913 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 490 | $14,606 | $16 |
| New patient visit (45+ min) | 90 | $13,668 | $152 |
| Programming of dual lead pacemaker system | 97 | $12,796 | $68 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $10,579 | $756 |
| Evaluation of implantable heart and blood vessel monitoring system | 130 | $9,969 | $40 |
| Telephone medical discussion with physician, 21-30 minutes | 64 | $8,616 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $7,553 | $184 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 258 | $6,525 | $24 |
| Injection of drug or substance into vein | 147 | $6,255 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $5,900 | $97 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 16 | $4,301 | $269 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 148 | $3,405 | None |
| Programming of multiple lead implantable defibrillator system | 14 | $2,610 | $97 |
| Electronic analysis of pacemaker to correct rapid heart rate | 11 | $2,571 | $234 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 26 | $2,376 | $91 |
| Programming of dual lead implantable defibrillator system | 16 | $2,045 | $85 |
| Insertion of heart rhythm monitor under skin | 25 | $2,019 | $81 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,499 | $107 |
| Short return visit (20+ min) | 13 | $1,261 | $74 |
| External shock to heart to regulate heart beat | 11 | $1,151 | $105 |
| Test for exercise-induced lung stress | 19 | $693 | $33 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $425 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $295 | $11 |
| Infusion, normal saline solution, 250 cc | 156 | $80 | None |
2019: 36 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 246 | $378,550 | $1,539 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 246 | $200,869 | $408 |
| Return visit (30+ min) | 649 | $121,269 | $98 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 134 | $101,785 | $760 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 268 | $58,043 | $206 |
| Long return visit (40+ min) | 189 | $31,079 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 777 | $27,163 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 329 | $24,644 | $69 |
| New patient visit (45+ min) | 179 | $24,376 | $136 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 30 | $21,761 | $725 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $21,206 | $180 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 64 | $13,255 | $23 |
| Programming of dual lead pacemaker system | 108 | $12,744 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $12,550 | $93 |
| Injection of drug or substance into vein | 246 | $9,879 | $40 |
| Evaluation of implantable heart and blood vessel monitoring system | 143 | $9,404 | $35 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 247 | $9,174 | None |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,306 | $437 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 31 | $8,227 | $257 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 65 | $7,201 | $13 |
| Electronic analysis of pacemaker to correct rapid heart rate | 31 | $6,932 | $224 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 66 | $5,912 | $90 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 227 | $5,243 | $23 |
| Programming of dual lead implantable defibrillator system | 23 | $3,426 | $74 |
| Programming of multiple lead implantable defibrillator system | 17 | $3,078 | $83 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 30 | $3,065 | $102 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $2,402 | $67 |
| New patient visit (60+ min) | 12 | $2,077 | $173 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $1,807 | $139 |
| External shock to heart to regulate heart beat | 13 | $1,409 | $101 |
| Programming of single lead pacemaker system | 16 | $1,375 | $53 |
| Insertion of heart rhythm monitor under skin | 15 | $1,163 | $78 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 52 | $940 | $11 |
| Test for exercise-induced lung stress | 27 | $870 | $32 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 23 | $710 | $31 |
| Infusion, normal saline solution, 250 cc | 249 | $121 | None |
2018: 35 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 208 | $317,195 | $1,525 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 212 | $167,266 | $394 |
| Return visit (30+ min) | 589 | $109,660 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $53,082 | $204 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 66 | $50,427 | $764 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 63 | $44,259 | $703 |
| Long return visit (40+ min) | 186 | $33,876 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 142 | $29,829 | $177 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 692 | $25,050 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $19,801 | $91 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 64 | $18,002 | $277 |
| New patient visit (45+ min) | 129 | $17,554 | $136 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 233 | $17,077 | $68 |
| Programming of dual lead pacemaker system | 100 | $11,245 | $53 |
| Injection of drug or substance into vein | 209 | $9,762 | $47 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 51 | $9,543 | $23 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 205 | $8,042 | None |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 61 | $5,898 | $91 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 58 | $5,769 | $99 |
| Programming of heart rhythm stimulation after drug infusion | 42 | $5,673 | $135 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 15 | $5,375 | $358 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 56 | $5,154 | $12 |
| Implantation patient-activated heart monitoring device | 28 | $5,074 | $181 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $4,332 | $65 |
| Electronic analysis of pacemaker to correct rapid heart rate | 20 | $4,304 | $215 |
| Programming of multiple lead implantable defibrillator system | 16 | $3,394 | $74 |
| Programming of dual lead implantable defibrillator system | 24 | $3,172 | $70 |
| Evaluation of implantable heart and blood vessel monitoring system | 40 | $2,951 | $30 |
| External shock to heart to regulate heart beat | 26 | $2,642 | $98 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 100 | $2,247 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 68 | $1,549 | $23 |
| Programming of single lead pacemaker system | 11 | $725 | $45 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 13 | $389 | $30 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 12 | $229 | $13 |
| Infusion, normal saline solution, 250 cc | 207 | $98 | None |
2017: 32 services
| Return visit (30+ min) | 597 | $117,747 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 175 | $41,453 | $232 |
| Long return visit (40+ min) | 175 | $32,394 | $130 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 38 | $27,544 | $725 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $26,207 | $181 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 655 | $25,533 | $16 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 40 | $14,493 | $345 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 143 | $13,648 | $93 |
| New patient visit (45+ min) | 94 | $13,159 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $12,433 | $93 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 30 | $6,827 | $24 |
| Programming of dual lead pacemaker system | 78 | $6,599 | $55 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,811 | $415 |
| Electronic analysis of pacemaker to correct rapid heart rate | 24 | $5,306 | $221 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 44 | $4,526 | $103 |
| New patient visit (60+ min) | 24 | $4,491 | $187 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 30 | $3,621 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 48 | $3,513 | $73 |
| Programming of heart rhythm stimulation after drug infusion | 24 | $3,351 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 44 | $2,715 | $58 |
| External shock to heart to regulate heart beat | 19 | $2,240 | $97 |
| External ekg recording for more than 48 hours up to 21 days | 61 | $1,751 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 67 | $1,592 | $11 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 61 | $1,518 | $24 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 11 | $1,451 | $132 |
| Programming of dual lead implantable defibrillator system | 17 | $1,402 | $78 |
| Evaluation of implantable heart and blood vessel monitoring system | 25 | $1,339 | $27 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 16 | $1,318 | $63 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,209 | $86 |
| Electrocardiogram (ecg) 2-day continuous | 41 | $1,158 | $28 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 41 | $1,004 | $24 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 21 | $647 | $31 |
2016: 20 services
| Return visit (30+ min) | 533 | $94,928 | $93 |
| Long return visit (40+ min) | 191 | $32,842 | $126 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 604 | $21,069 | $15 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 20 | $14,125 | $706 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $12,902 | $174 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 28 | $9,272 | $331 |
| New patient visit (45+ min) | 62 | $8,839 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $7,279 | $90 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,955 | $450 |
| Electronic analysis of pacemaker to correct rapid heart rate | 20 | $4,239 | $212 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $3,978 | $284 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 47 | $3,376 | $72 |
| New patient visit (60+ min) | 19 | $3,316 | $175 |
| Implantation patient-activated heart monitoring device | 16 | $3,135 | $196 |
| Programming of heart rhythm stimulation after drug infusion | 19 | $2,526 | $133 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 24 | $2,355 | $98 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 47 | $2,055 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 24 | $1,380 | $55 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 17 | $533 | $30 |
| Infusion, normal saline solution, 250 cc | 47 | $141 | None |
2015: 14 services
| Return visit (30+ min) | 535 | $101,866 | $93 |
| Long return visit (40+ min) | 204 | $40,174 | $130 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 33 | $24,126 | $731 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 596 | $23,330 | $16 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $17,199 | $179 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 43 | $15,286 | $340 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $11,745 | $979 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $8,651 | $93 |
| New patient visit (45+ min) | 48 | $7,107 | $148 |
| New patient visit (60+ min) | 32 | $6,083 | $190 |
| Programming of heart rhythm stimulation after drug infusion | 35 | $5,163 | $140 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 32 | $3,275 | $102 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 38 | $2,232 | $57 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $1,578 | $132 |
2014: 15 services
| Return visit (30+ min) | 585 | $116,174 | $94 |
| Long return visit (40+ min) | 186 | $33,878 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 647 | $24,704 | $15 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 27 | $19,435 | $720 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $13,195 | $178 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 33 | $11,475 | $337 |
| New patient visit (45+ min) | 74 | $10,281 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $8,410 | $92 |
| New patient visit (60+ min) | 35 | $6,364 | $182 |
| Programming of heart rhythm stimulation after drug infusion | 34 | $4,813 | $138 |
| Electronic analysis of pacemaker to correct rapid heart rate | 14 | $3,283 | $219 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 32 | $3,237 | $101 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 30 | $3,152 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $1,493 | $55 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 15 | $494 | $31 |
2013: 16 services
| Return visit (30+ min) | 586 | $122,594 | $95 |
| Long return visit (40+ min) | 193 | $30,809 | $127 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 659 | $28,307 | $17 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 24 | $16,509 | $688 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,029 | $175 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 28 | $9,956 | $321 |
| New patient visit (45+ min) | 61 | $9,000 | $148 |
| New patient visit (60+ min) | 47 | $8,180 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $7,725 | $90 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,871 | $452 |
| Electronic analysis of pacemaker to correct rapid heart rate | 14 | $2,947 | $211 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 18 | $2,704 | $8 |
| Programming of heart rhythm stimulation after drug infusion | 19 | $2,487 | $131 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 16 | $1,538 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $885 | $55 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 20 | $595 | $30 |
Medicaid work
$608 in 2024
Medicaid paid $608 for 348 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 195 | $458 |
| Return visit (30+ min) | 153 | $150 |
| 2024 | 348 | 2 | 28 | $608 |
| 2023 | 406 | 2 | 30 | $648 |
| 2022 | 451 | 2 | 32 | $891 |
| 2021 | 351 | 4 | 33 | $722 |
| 2020 | 273 | 4 | 25 | $716 |
| 2019 | 649 | 5 | 23 | $2,922 |
| 2018 | 604 | 6 | 32 | $3,718 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 250 | $548 |
| Return visit (30+ min) | 156 | $100 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 270 | $711 |
| Return visit (30+ min) | 181 | $180 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 161 | $477 |
| Return visit (30+ min) | 147 | $245 |
| Patient screened for future fall risk; documentation of no falls in the past year or only 1 fall without injury in the past year (GER) | 30 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 13 | $0 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 93 | $662 |
| Return visit (30+ min) | 118 | $54 |
| TOBACCO NON-USER | 48 | $0 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 14 | $0 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 227 | $2,847 |
| Return visit (30+ min) | 155 | $75 |
| TOBACCO NON-USER | 71 | $0 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 166 | $0 |
| Asa/antiplat ther used | 30 | $0 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 255 | $3,575 |
| Return visit (30+ min) | 188 | $143 |
| TOBACCO NON-USER | 46 | $0 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 87 | $0 |
| Asa/antiplat ther used | 14 | $0 |
| Fda approved oral anticoagulant is prescribed | 14 | $0 |
Drugs they prescribed that Part D paid
$1,244,208
Pharmacies billed $1,244,208 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 5,009) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
4,039 generic and fewer than 11 brand-name prescriptions · $1,244,208 in drug cost · 25 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 385 | $523,437 | $1,360 |
| Xarelto | 299 | $379,356 | $1,269 |
| Vascepa | 107 | $69,225 | $647 |
| Entresto | 23 | $37,709 | $1,640 |
| Multaq | 33 | $37,435 | $1,134 |
See all 56 drugs
| Eliquis | 385 | $523,437 | $1,360 |
| Xarelto | 299 | $379,356 | $1,269 |
| Vascepa | 107 | $69,225 | $647 |
| Entresto | 23 | $37,709 | $1,640 |
| Multaq | 33 | $37,435 | $1,134 |
| Dofetilide | 121 | $28,532 | $236 |
| Icosapent Ethyl | 38 | $15,298 | $403 |
| Repatha Sureclick | 16 | $12,544 | $784 |
| Metoprolol | 733 | $10,772 | $15 |
| Rosuvastatin | 296 | $8,010 | $27 |
| Amiodarone | 91 | $5,891 | $65 |
| Nebivolol | 77 | $5,546 | $72 |
| Dabigatran Etexilate | 13 | $5,360 | $412 |
| Flecainide Acetate | 106 | $4,708 | $44 |
| Propafenone | 95 | $4,577 | $48 |
| Valsartan | 108 | $4,421 | $41 |
| Diltiazem 12hr Er | 11 | $3,327 | $302 |
| Ranolazine Er | 35 | $3,312 | $95 |
| Atorvastatin | 295 | $2,969 | $10 |
| Amlodipine Besylate | 289 | $2,210 | $8 |
| Losartan | 192 | $2,102 | $11 |
| Potassium Chloride | 75 | $1,853 | $25 |
| Midodrine | 17 | $1,798 | $106 |
| Sotalol | 102 | $1,716 | $17 |
| Diltiazem 24hr Er (Cd) | 32 | $1,575 | $49 |
| Clopidogrel | 110 | $1,412 | $13 |
| Isosorbide Mononitrate Er | 76 | $1,279 | $17 |
| Lisinopril | 97 | $799 | $8 |
| Furosemide | 135 | $763 | $6 |
| Ezetimibe | 20 | $754 | $38 |
| Prasugrel | 15 | $735 | $49 |
| Bumetanide | 24 | $643 | $27 |
| Diltiazem 24hr Er | 17 | $588 | $35 |
| Spironolactone | 44 | $572 | $13 |
| Digoxin | 12 | $536 | $45 |
| Pravastatin | 70 | $522 | $7 |
| Irbesartan | 22 | $518 | $24 |
| Atenolol | 60 | $515 | $9 |
| Losartan-Hydrochlorothiazide | 17 | $474 | $28 |
| Olmesartan Medoxomil | 20 | $462 | $23 |
| Nitroglycerin | 45 | $449 | $10 |
| Hydrochlorothiazide | 84 | $428 | $5 |
| Carvedilol | 64 | $412 | $6 |
| Simvastatin | 42 | $344 | $8 |
| Metolazone | 13 | $301 | $23 |
| Diltiazem 24hr Er (Xr) | 12 | $281 | $23 |
| Propranolol | 14 | $266 | $19 |
| Clonidine | 42 | $222 | $5 |
| Metoprolol | 35 | $207 | $6 |
| Ramipril | 18 | $184 | $10 |
| Hydralazine | 11 | $113 | $10 |
| Lovastatin | 15 | $104 | $7 |
| Pantoprazole | 11 | $103 | $9 |
| Cephalexin | 18 | $81 | $5 |
| Lisinopril-Hydrochlorothiazide | 12 | $48 | $4 |
| Metformin | 11 | $28 | $3 |
Year by year
| 2024 | 5,009 | 599 | 0% (0) | None | $1,244,208 |
| 2023 | 5,026 | 611 | 0% (0) | 18% | $1,403,962 |
| 2022 | 5,116 | 605 | 0% (0) | None | $1,338,447 |
| 2021 | 5,561 | 591 | 0% (0) | 24% | $1,481,811 |
| 2020 | 6,087 | 620 | 0% (0) | 27% | $1,474,292 |
| 2019 | 5,652 | 608 | 0% (0) | None | $1,215,203 |
| 2018 | 5,141 | 523 | None | None | $985,832 |
| 2017 | 4,960 | 497 | 0% (0) | None | $836,035 |
| 2016 | 5,536 | 460 | None | 32% | $851,400 |
| 2015 | 6,076 | 487 | None | 33% | $727,330 |
| 2014 | 6,484 | 495 | None | 33% | $644,529 |
| 2013 | 6,447 | 494 | 0% (0) | None | $510,780 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 56 drugs
| Eliquis | 329 | $508,165 | $1,545 |
| Xarelto | 306 | $432,003 | $1,412 |
| Vascepa | 84 | $84,444 | $1,005 |
| Dofetilide | 112 | $53,384 | $477 |
| Entresto | 29 | $48,977 | $1,689 |
| Multaq | 27 | $35,919 | $1,330 |
| Icosapent Ethyl | 50 | $30,313 | $606 |
| Metoprolol | 666 | $16,305 | $24 |
| Rosuvastatin | 355 | $12,400 | $35 |
| Repatha Sureclick | 14 | $11,729 | $838 |
| Nebivolol | 73 | $9,677 | $133 |
| Dabigatran Etexilate | 17 | $9,646 | $567 |
| Ranolazine Er | 26 | $9,273 | $357 |
| Flecainide Acetate | 109 | $8,318 | $76 |
| Bystolic | 11 | $7,513 | $683 |
| Livalo | 13 | $6,385 | $491 |
| Valsartan | 85 | $6,082 | $72 |
| Propafenone | 104 | $5,691 | $55 |
| Amiodarone | 121 | $5,295 | $44 |
| Atorvastatin | 284 | $4,390 | $15 |
| Amlodipine Besylate | 282 | $4,152 | $15 |
| Losartan | 197 | $3,982 | $20 |
| Sotalol | 125 | $3,706 | $30 |
| Midodrine | 15 | $2,587 | $172 |
| Clopidogrel | 119 | $2,053 | $17 |
| Isosorbide Mononitrate Er | 89 | $1,998 | $22 |
| Potassium Chloride | 56 | $1,933 | $35 |
| Pravastatin | 70 | $1,510 | $22 |
| Lisinopril | 109 | $1,447 | $13 |
| Diltiazem 24hr Er (Cd) | 24 | $1,360 | $57 |
| Nitroglycerin | 70 | $1,099 | $16 |
| Furosemide | 135 | $1,055 | $8 |
| Losartan-Hydrochlorothiazide | 23 | $1,002 | $44 |
| Carvedilol | 66 | $992 | $15 |
| Hydrochlorothiazide | 97 | $937 | $10 |
| Ezetimibe | 15 | $872 | $58 |
| Metolazone | 14 | $864 | $62 |
| Olmesartan Medoxomil | 23 | $841 | $37 |
| Eplerenone | 12 | $831 | $69 |
| Clonidine | 58 | $733 | $13 |
| Irbesartan | 20 | $727 | $36 |
| Valsartan-Hydrochlorothiazide | 17 | $677 | $40 |
| Simvastatin | 43 | $650 | $15 |
| Spironolactone | 44 | $641 | $15 |
| Cephalexin | 39 | $637 | $16 |
| Nifedipine Er | 11 | $557 | $51 |
| Prasugrel | 12 | $534 | $45 |
| Atenolol | 48 | $502 | $10 |
| Diltiazem 24hr Er (Xr) | 14 | $488 | $35 |
| Diltiazem 24hr Er | 14 | $463 | $33 |
| Hydralazine | 18 | $445 | $25 |
| Metoprolol | 35 | $432 | $12 |
| Bumetanide | 22 | $340 | $15 |
| Pantoprazole | 11 | $154 | $14 |
| Warfarin | 15 | $148 | $10 |
| Lovastatin | 11 | $117 | $11 |
2022: 54 drugs
| Eliquis | 296 | $409,119 | $1,382 |
| Xarelto | 306 | $386,057 | $1,262 |
| Vascepa | 126 | $109,656 | $870 |
| Pradaxa | 55 | $70,763 | $1,287 |
| Dofetilide | 92 | $55,539 | $604 |
| Entresto | 35 | $54,014 | $1,543 |
| Multaq | 16 | $27,482 | $1,718 |
| Rosuvastatin | 383 | $20,982 | $55 |
| Icosapent Ethyl | 34 | $14,320 | $421 |
| Metoprolol | 612 | $13,755 | $22 |
| Bystolic | 19 | $13,237 | $697 |
| Brilinta | 11 | $11,188 | $1,017 |
| Nebivolol | 63 | $10,564 | $168 |
| Ranolazine Er | 43 | $9,632 | $224 |
| Repatha Sureclick | 16 | $9,287 | $580 |
| Flecainide Acetate | 106 | $8,651 | $82 |
| Propafenone | 131 | $7,000 | $53 |
| Midodrine | 30 | $6,209 | $207 |
| Valsartan | 90 | $6,193 | $69 |
| Atorvastatin | 298 | $4,026 | $14 |
| Sotalol | 141 | $3,509 | $25 |
| Eplerenone | 17 | $3,336 | $196 |
| Losartan | 207 | $3,271 | $16 |
| Amlodipine Besylate | 243 | $2,920 | $12 |
| Amiodarone | 55 | $2,637 | $48 |
| Potassium Chloride | 86 | $2,567 | $30 |
| Losartan-Hydrochlorothiazide | 30 | $2,009 | $67 |
| Olmesartan Medoxomil | 47 | $1,810 | $39 |
| Clopidogrel | 128 | $1,736 | $14 |
| Prasugrel | 13 | $1,657 | $127 |
| Irbesartan | 35 | $1,587 | $45 |
| Ezetimibe | 19 | $1,540 | $81 |
| Diltiazem 24hr Er (Cd) | 39 | $1,454 | $37 |
| Isosorbide Mononitrate Er | 79 | $1,395 | $18 |
| Lisinopril | 91 | $1,233 | $14 |
| Pravastatin | 68 | $1,221 | $18 |
| Furosemide | 158 | $1,010 | $6 |
| Nitroglycerin | 50 | $972 | $19 |
| Metolazone | 18 | $971 | $54 |
| Valsartan-Hydrochlorothiazide | 12 | $889 | $74 |
| Clonidine | 48 | $822 | $17 |
| Hydrochlorothiazide | 126 | $811 | $6 |
| Carvedilol | 79 | $774 | $10 |
| Spironolactone | 42 | $500 | $12 |
| Hydralazine | 27 | $490 | $18 |
| Bumetanide | 21 | $455 | $22 |
| Simvastatin | 48 | $403 | $8 |
| Cephalexin | 46 | $365 | $8 |
| Metoprolol | 49 | $307 | $6 |
| Propranolol | 12 | $306 | $25 |
| Atenolol | 40 | $283 | $7 |
| Warfarin | 21 | $266 | $13 |
| Lisinopril-Hydrochlorothiazide | 13 | $103 | $8 |
| Lovastatin | 11 | $46 | $4 |
2021: 58 drugs
| Xarelto | 398 | $437,310 | $1,099 |
| Eliquis | 351 | $428,809 | $1,222 |
| Vascepa | 147 | $116,148 | $790 |
| Pradaxa | 77 | $86,028 | $1,117 |
| Dofetilide | 117 | $63,980 | $547 |
| Entresto | 54 | $63,865 | $1,183 |
| Bystolic | 88 | $46,218 | $525 |
| Multaq | 16 | $22,422 | $1,401 |
| Rosuvastatin | 403 | $21,692 | $54 |
| Brilinta | 22 | $21,336 | $970 |
| Metoprolol | 638 | $15,323 | $24 |
| Ranolazine Er | 55 | $11,223 | $204 |
| Repatha Sureclick | 22 | $10,943 | $497 |
| Flecainide Acetate | 84 | $8,762 | $104 |
| Propafenone | 130 | $7,503 | $58 |
| Valsartan | 77 | $6,682 | $87 |
| Livalo | 12 | $6,636 | $553 |
| Atorvastatin | 313 | $4,825 | $15 |
| Midodrine | 27 | $4,469 | $166 |
| Olmesartan Medoxomil | 62 | $4,297 | $69 |
| Losartan | 234 | $3,961 | $17 |
| Sotalol | 152 | $3,518 | $23 |
| Eplerenone | 22 | $3,318 | $151 |
| Amlodipine Besylate | 272 | $2,948 | $11 |
| Potassium Chloride | 80 | $2,523 | $32 |
| Amiodarone | 60 | $2,445 | $41 |
| Ezetimibe | 24 | $2,423 | $101 |
| Diltiazem 12hr Er | 13 | $2,374 | $183 |
| Pravastatin | 108 | $2,172 | $20 |
| Diltiazem 24hr Er (Cd) | 41 | $1,887 | $46 |
| Isosorbide Mononitrate Er | 79 | $1,782 | $23 |
| Dilt-Xr | 21 | $1,502 | $72 |
| Clopidogrel | 113 | $1,317 | $12 |
| Losartan-Hydrochlorothiazide | 37 | $1,286 | $35 |
| Diltiazem 24hr Er | 14 | $1,125 | $80 |
| Hydrochlorothiazide | 157 | $1,082 | $7 |
| Furosemide | 155 | $1,013 | $7 |
| Clonidine | 40 | $887 | $22 |
| Nitroglycerin | 49 | $877 | $18 |
| Carvedilol | 66 | $874 | $13 |
| Bumetanide | 23 | $867 | $38 |
| Metolazone | 12 | $839 | $70 |
| Irbesartan | 30 | $825 | $28 |
| Lisinopril | 91 | $710 | $8 |
| Enalapril Maleate | 13 | $523 | $40 |
| Atenolol | 48 | $514 | $11 |
| Propranolol | 17 | $473 | $28 |
| Spironolactone | 53 | $412 | $8 |
| Metoprolol | 41 | $312 | $8 |
| Warfarin | 20 | $302 | $15 |
| Hydralazine | 13 | $299 | $23 |
| Simvastatin | 54 | $268 | $5 |
| Cephalexin | 33 | $214 | $6 |
| Benazepril | 11 | $197 | $18 |
| Allopurinol | 11 | $142 | $13 |
| Lisinopril-Hydrochlorothiazide | 15 | $81 | $5 |
| Lovastatin | 13 | $74 | $6 |
| Gabapentin | 12 | $60 | $5 |
2020: 56 drugs
| Xarelto | 456 | $475,550 | $1,043 |
| Eliquis | 382 | $372,192 | $974 |
| Pradaxa | 119 | $110,718 | $930 |
| Vascepa | 150 | $104,831 | $699 |
| Dofetilide | 158 | $78,747 | $498 |
| Entresto | 65 | $53,028 | $816 |
| Bystolic | 109 | $50,661 | $465 |
| Brilinta | 44 | $31,851 | $724 |
| Rosuvastatin | 267 | $16,730 | $63 |
| Metoprolol | 669 | $14,185 | $21 |
| Ranolazine Er | 59 | $10,471 | $177 |
| Flecainide Acetate | 91 | $9,460 | $104 |
| Repatha Sureclick | 19 | $8,942 | $471 |
| Atorvastatin | 398 | $5,700 | $14 |
| Propafenone | 111 | $5,649 | $51 |
| Midodrine | 40 | $5,202 | $130 |
| Sotalol | 196 | $5,172 | $26 |
| Eplerenone | 27 | $4,938 | $183 |
| Olmesartan Medoxomil | 69 | $4,792 | $69 |
| Valsartan | 61 | $4,544 | $74 |
| Pravastatin | 174 | $3,600 | $21 |
| Losartan | 225 | $3,507 | $16 |
| Amlodipine Besylate | 338 | $2,724 | $8 |
| Irbesartan | 43 | $2,203 | $51 |
| Diltiazem 24hr Er (Cd) | 44 | $2,097 | $48 |
| Potassium Chloride | 81 | $2,009 | $25 |
| Clopidogrel | 124 | $2,001 | $16 |
| Omega-3 Acid Ethyl Esters | 13 | $1,964 | $151 |
| Metolazone | 37 | $1,928 | $52 |
| Ezetimibe | 28 | $1,903 | $68 |
| Losartan-Hydrochlorothiazide | 34 | $1,897 | $56 |
| Diltiazem 12hr Er | 13 | $1,708 | $131 |
| Amiodarone | 71 | $1,599 | $23 |
| Isosorbide Mononitrate Er | 59 | $1,596 | $27 |
| Nitroglycerin | 54 | $1,588 | $29 |
| Dilt-Xr | 21 | $1,395 | $66 |
| Hydrochlorothiazide | 153 | $1,201 | $8 |
| Diltiazem 24hr Er | 14 | $1,039 | $74 |
| Furosemide | 162 | $1,007 | $6 |
| Lisinopril | 118 | $934 | $8 |
| Carvedilol | 83 | $923 | $11 |
| Prasugrel | 20 | $789 | $39 |
| Clonidine | 26 | $745 | $29 |
| Bumetanide | 17 | $738 | $43 |
| Spironolactone | 72 | $687 | $10 |
| Warfarin | 26 | $559 | $22 |
| Atenolol | 47 | $505 | $11 |
| Propranolol | 12 | $412 | $34 |
| Pantoprazole | 14 | $327 | $23 |
| Simvastatin | 72 | $322 | $4 |
| Metoprolol | 59 | $318 | $5 |
| Enalapril Maleate | 11 | $277 | $25 |
| Hydralazine | 11 | $244 | $22 |
| Gabapentin | 25 | $195 | $8 |
| Cephalexin | 31 | $147 | $5 |
| Lisinopril-Hydrochlorothiazide | 14 | $91 | $7 |
2019: 56 drugs
| Xarelto | 313 | $308,856 | $987 |
| Eliquis | 379 | $295,806 | $780 |
| Pradaxa | 110 | $99,246 | $902 |
| Vascepa | 144 | $94,306 | $655 |
| Dofetilide | 174 | $80,312 | $462 |
| Bystolic | 110 | $43,018 | $391 |
| Ranexa | 53 | $35,252 | $665 |
| Entresto | 51 | $32,497 | $637 |
| Brilinta | 29 | $22,333 | $770 |
| Tikosyn | 22 | $21,004 | $955 |
| Ranolazine Er | 57 | $18,509 | $325 |
| Metoprolol | 514 | $14,911 | $29 |
| Rosuvastatin | 156 | $11,027 | $71 |
| Atorvastatin | 367 | $5,908 | $16 |
| Flecainide Acetate | 74 | $5,884 | $80 |
| Sotalol | 215 | $5,749 | $27 |
| Pravastatin | 220 | $5,142 | $23 |
| Propafenone | 115 | $4,658 | $41 |
| Prasugrel | 26 | $4,367 | $168 |
| Eplerenone | 20 | $3,918 | $196 |
| Olmesartan Medoxomil | 40 | $3,835 | $96 |
| Amlodipine Besylate | 320 | $3,766 | $12 |
| Midodrine | 35 | $3,585 | $102 |
| Losartan | 220 | $3,265 | $15 |
| Clopidogrel | 166 | $2,577 | $16 |
| Irbesartan | 44 | $2,402 | $55 |
| Isosorbide Mononitrate Er | 57 | $2,313 | $41 |
| Amiodarone | 68 | $2,143 | $32 |
| Telmisartan | 12 | $1,819 | $152 |
| Potassium Chloride | 66 | $1,727 | $26 |
| Omega-3 Acid Ethyl Esters | 11 | $1,695 | $154 |
| Diltiazem 24hr Er (Cd) | 37 | $1,642 | $44 |
| Carvedilol | 99 | $1,565 | $16 |
| Valsartan | 34 | $1,507 | $44 |
| Nadolol | 11 | $1,378 | $125 |
| Ezetimibe | 14 | $1,267 | $91 |
| Lisinopril | 127 | $1,132 | $9 |
| Hydrochlorothiazide | 133 | $1,130 | $8 |
| Nitroglycerin | 56 | $1,088 | $19 |
| Dilt-Xr | 16 | $950 | $59 |
| Furosemide | 140 | $855 | $6 |
| Simvastatin | 76 | $777 | $10 |
| Losartan-Hydrochlorothiazide | 56 | $770 | $14 |
| Atenolol | 46 | $656 | $14 |
| Warfarin | 40 | $650 | $16 |
| Ramipril | 18 | $620 | $34 |
| Spironolactone | 77 | $594 | $8 |
| Metoprolol | 66 | $563 | $9 |
| Propranolol | 11 | $530 | $48 |
| Lovastatin | 24 | $404 | $17 |
| Cephalexin | 36 | $347 | $10 |
| Clonidine | 15 | $329 | $22 |
| Levothyroxine | 27 | $296 | $11 |
| Pantoprazole | 12 | $253 | $21 |
| Gabapentin | 17 | $195 | $11 |
| Bisoprolol-Hydrochlorothiazide | 11 | $27 | $2 |
2018: 60 drugs
| Eliquis | 295 | $226,481 | $768 |
| Xarelto | 232 | $210,086 | $906 |
| Dofetilide | 209 | $101,111 | $484 |
| Ranexa | 141 | $93,353 | $662 |
| Pradaxa | 94 | $77,555 | $825 |
| Vascepa | 70 | $39,347 | $562 |
| Bystolic | 86 | $30,297 | $352 |
| Entresto | 32 | $22,521 | $704 |
| Tikosyn | 12 | $21,541 | $1,795 |
| Brilinta | 21 | $14,253 | $679 |
| Metoprolol | 462 | $14,100 | $31 |
| Rosuvastatin | 137 | $7,571 | $55 |
| Flecainide Acetate | 93 | $5,651 | $61 |
| Sotalol | 281 | $5,456 | $19 |
| Colcrys | 12 | $5,150 | $429 |
| Plavix | 14 | $5,121 | $366 |
| Atorvastatin | 282 | $4,889 | $17 |
| Eplerenone | 35 | $4,522 | $129 |
| Prasugrel | 21 | $4,449 | $212 |
| Ezetimibe-Simvastatin | 19 | $3,962 | $209 |
| Omega-3 Acid Ethyl Esters | 32 | $3,723 | $116 |
| Pravastatin | 178 | $3,596 | $20 |
| Amiodarone | 81 | $3,209 | $40 |
| Clopidogrel | 209 | $2,846 | $14 |
| Midodrine | 21 | $2,799 | $133 |
| Valsartan | 49 | $2,747 | $56 |
| Nadolol | 17 | $2,393 | $141 |
| Amlodipine Besylate | 246 | $2,237 | $9 |
| Propafenone | 79 | $2,113 | $27 |
| Losartan | 173 | $2,074 | $12 |
| Isosorbide Mononitrate Er | 34 | $1,570 | $46 |
| Irbesartan | 45 | $1,540 | $34 |
| Olmesartan Medoxomil | 29 | $1,445 | $50 |
| Nitroglycerin | 49 | $1,388 | $28 |
| Potassium Chloride | 40 | $1,065 | $27 |
| Hydrochlorothiazide | 127 | $1,007 | $8 |
| Carvedilol | 95 | $945 | $10 |
| Warfarin | 39 | $905 | $23 |
| Spironolactone | 85 | $820 | $10 |
| Lisinopril | 115 | $812 | $7 |
| Dilt-Xr | 14 | $779 | $56 |
| Diltiazem 24hr Er (Cd) | 29 | $728 | $25 |
| Losartan-Hydrochlorothiazide | 47 | $722 | $15 |
| Simvastatin | 80 | $679 | $8 |
| Furosemide | 147 | $538 | $4 |
| Metoprolol | 66 | $467 | $7 |
| Atenolol | 34 | $436 | $13 |
| Lovastatin | 25 | $395 | $16 |
| Propranolol | 14 | $354 | $25 |
| Ramipril | 13 | $353 | $27 |
| Enalapril Maleate | 16 | $327 | $20 |
| Clonidine | 15 | $262 | $17 |
| Pantoprazole | 11 | $232 | $21 |
| Cephalexin | 31 | $225 | $7 |
| Digoxin | 11 | $183 | $17 |
| Levothyroxine | 13 | $181 | $14 |
| Allopurinol | 12 | $150 | $13 |
| Gabapentin | 12 | $130 | $11 |
| Metformin | 15 | $101 | $7 |
| Prednisone | 13 | $34 | $3 |
2017: 57 drugs
| Xarelto | 236 | $170,393 | $722 |
| Eliquis | 260 | $169,851 | $653 |
| Dofetilide | 206 | $86,961 | $422 |
| Ranexa | 135 | $81,873 | $606 |
| Pradaxa | 113 | $74,098 | $656 |
| Tikosyn | 32 | $24,274 | $759 |
| Effient | 20 | $19,919 | $996 |
| Multaq | 23 | $18,818 | $818 |
| Vascepa | 39 | $18,556 | $476 |
| Bystolic | 72 | $17,914 | $249 |
| Metoprolol | 516 | $14,051 | $27 |
| Brilinta | 17 | $9,176 | $540 |
| Rosuvastatin | 109 | $7,186 | $66 |
| Flecainide Acetate | 104 | $6,208 | $60 |
| Omega-3 Acid Ethyl Esters | 26 | $5,859 | $225 |
| Sotalol | 255 | $5,238 | $21 |
| Propafenone Hcl Er | 12 | $4,856 | $405 |
| Atorvastatin | 279 | $4,435 | $16 |
| Pravastatin | 202 | $3,636 | $18 |
| Olmesartan Medoxomil | 24 | $3,562 | $148 |
| Plavix | 13 | $3,360 | $258 |
| Ezetimibe-Simvastatin | 19 | $3,287 | $173 |
| Coreg Cr | 12 | $3,223 | $269 |
| Clopidogrel | 223 | $3,015 | $14 |
| Eplerenone | 32 | $2,638 | $82 |
| Amiodarone | 85 | $2,633 | $31 |
| Nadolol | 16 | $2,318 | $145 |
| Losartan | 181 | $1,908 | $11 |
| Amlodipine Besylate | 248 | $1,839 | $7 |
| Nitroglycerin | 48 | $1,761 | $37 |
| Isosorbide Mononitrate Er | 46 | $1,516 | $33 |
| Valsartan | 32 | $1,434 | $45 |
| Diltiazem 24hr Er | 39 | $1,286 | $33 |
| Midodrine | 15 | $1,277 | $85 |
| Propafenone | 46 | $1,176 | $26 |
| Potassium Chloride | 32 | $1,087 | $34 |
| Metolazone | 18 | $1,053 | $58 |
| Losartan-Hydrochlorothiazide | 66 | $919 | $14 |
| Warfarin | 36 | $845 | $23 |
| Fenofibrate | 16 | $739 | $46 |
| Hydrochlorothiazide | 90 | $736 | $8 |
| Carvedilol | 73 | $675 | $9 |
| Lisinopril | 87 | $664 | $8 |
| Atenolol | 58 | $595 | $10 |
| Nitroglycerin Patch | 14 | $553 | $40 |
| Simvastatin | 68 | $523 | $8 |
| Irbesartan | 21 | $509 | $24 |
| Ramipril | 20 | $451 | $23 |
| Lovastatin | 29 | $442 | $15 |
| Furosemide | 109 | $420 | $4 |
| Spironolactone | 54 | $377 | $7 |
| Clonidine | 24 | $334 | $14 |
| Quinapril | 13 | $288 | $22 |
| Allopurinol | 20 | $278 | $14 |
| Metoprolol | 58 | $250 | $4 |
| Cephalexin | 25 | $142 | $6 |
| Gabapentin | 12 | $78 | $7 |
2016: 65 drugs
| Eliquis | 276 | $155,146 | $562 |
| Xarelto | 179 | $110,959 | $620 |
| Tikosyn | 194 | $105,695 | $545 |
| Ranexa | 168 | $101,463 | $604 |
| Pradaxa | 122 | $74,961 | $614 |
| Crestor | 67 | $38,885 | $580 |
| Effient | 31 | $26,687 | $861 |
| Multaq | 34 | $22,950 | $675 |
| Bystolic | 88 | $20,670 | $235 |
| Dofetilide | 43 | $20,632 | $480 |
| Benicar | 46 | $16,551 | $360 |
| Vytorin | 41 | $13,618 | $332 |
| Metoprolol | 472 | $12,124 | $26 |
| Omega-3 Acid Ethyl Esters | 52 | $8,758 | $168 |
| Vascepa | 19 | $7,301 | $384 |
| Zetia | 11 | $7,070 | $643 |
| Plavix | 25 | $6,917 | $277 |
| Atorvastatin | 352 | $5,895 | $17 |
| Pravastatin | 252 | $5,761 | $23 |
| Propafenone Hcl Er | 13 | $5,729 | $441 |
| Livalo | 21 | $5,728 | $273 |
| Sotalol | 294 | $4,443 | $15 |
| Clopidogrel | 260 | $4,171 | $16 |
| Rosuvastatin | 23 | $3,282 | $143 |
| Coreg Cr | 12 | $2,967 | $247 |
| Losartan | 233 | $2,302 | $10 |
| Niacin Er | 23 | $2,291 | $100 |
| Nadolol | 15 | $2,090 | $139 |
| Flecainide Acetate | 51 | $1,989 | $39 |
| Amiodarone | 106 | $1,916 | $18 |
| Eplerenone | 24 | $1,868 | $78 |
| Isosorbide Mononitrate Er | 67 | $1,821 | $27 |
| Amlodipine Besylate | 296 | $1,734 | $6 |
| Valsartan | 21 | $1,691 | $81 |
| Potassium Chloride | 52 | $1,611 | $31 |
| Nitrostat | 48 | $1,379 | $29 |
| Warfarin | 45 | $1,303 | $29 |
| Diltiazem 24hr Er | 31 | $1,136 | $37 |
| Irbesartan | 20 | $985 | $49 |
| Lisinopril | 128 | $926 | $7 |
| Carvedilol | 107 | $922 | $9 |
| Fenofibrate | 11 | $876 | $80 |
| Propafenone | 45 | $853 | $19 |
| Simvastatin | 127 | $816 | $6 |
| Hydrochlorothiazide | 107 | $802 | $7 |
| Losartan-Hydrochlorothiazide | 55 | $749 | $14 |
| Nitroglycerin Patch | 19 | $729 | $38 |
| Midodrine | 12 | $728 | $61 |
| Metolazone | 15 | $716 | $48 |
| Ramipril | 30 | $704 | $23 |
| Fenofibrate | 17 | $681 | $40 |
| Atenolol | 81 | $628 | $8 |
| Metoprolol | 79 | $586 | $7 |
| Enalapril Maleate | 17 | $575 | $34 |
| Fenofibrate | 16 | $565 | $35 |
| Lovastatin | 28 | $486 | $17 |
| Furosemide | 125 | $457 | $4 |
| Quinapril | 15 | $352 | $23 |
| Spironolactone | 53 | $348 | $7 |
| Bumetanide | 14 | $216 | $15 |
| Allopurinol | 20 | $205 | $10 |
| Pantoprazole | 15 | $194 | $13 |
| Labetalol | 12 | $181 | $15 |
| Metformin | 17 | $169 | $10 |
| Clonidine | 17 | $131 | $8 |
2015: 62 drugs
| Xarelto | 269 | $132,555 | $493 |
| Ranexa | 206 | $93,309 | $453 |
| Tikosyn | 216 | $77,960 | $361 |
| Eliquis | 146 | $69,598 | $477 |
| Pradaxa | 102 | $56,276 | $552 |
| Crestor | 94 | $44,850 | $477 |
| Benicar | 62 | $22,270 | $359 |
| Bystolic | 112 | $22,115 | $197 |
| Effient | 23 | $19,498 | $848 |
| Multaq | 32 | $18,732 | $585 |
| Omega-3 Acid Ethyl Esters | 84 | $18,051 | $215 |
| Metoprolol | 469 | $14,821 | $32 |
| Vytorin | 32 | $9,665 | $302 |
| Zetia | 24 | $8,611 | $359 |
| Niacin Er | 53 | $8,488 | $160 |
| Plavix | 30 | $7,875 | $262 |
| Pravastatin | 294 | $7,341 | $25 |
| Atorvastatin | 395 | $6,784 | $17 |
| Amiodarone | 138 | $5,147 | $37 |
| Clopidogrel | 415 | $5,100 | $12 |
| Simcor | 16 | $4,284 | $268 |
| Sotalol | 214 | $3,344 | $16 |
| Coreg Cr | 12 | $2,576 | $215 |
| Eplerenone | 29 | $2,330 | $80 |
| Losartan | 240 | $2,146 | $9 |
| Flecainide Acetate | 56 | $1,922 | $34 |
| Amlodipine Besylate | 316 | $1,816 | $6 |
| Warfarin | 91 | $1,741 | $19 |
| Fenofibrate | 22 | $1,622 | $74 |
| Nitrostat | 93 | $1,589 | $17 |
| Isosorbide Mononitrate Er | 96 | $1,463 | $15 |
| Procardia Xl | 11 | $1,368 | $124 |
| Simvastatin | 168 | $1,332 | $8 |
| Valsartan | 14 | $1,228 | $88 |
| Carvedilol | 128 | $1,202 | $9 |
| Lisinopril | 137 | $1,187 | $9 |
| Propafenone | 61 | $1,070 | $18 |
| Atenolol | 107 | $962 | $9 |
| Losartan-Hydrochlorothiazide | 85 | $948 | $11 |
| Fenofibrate | 12 | $941 | $78 |
| Irbesartan | 19 | $906 | $48 |
| Diltiazem Er | 20 | $847 | $42 |
| Potassium Chloride | 28 | $789 | $28 |
| Fenofibrate | 21 | $751 | $36 |
| Ramipril | 37 | $736 | $20 |
| Metoprolol | 101 | $684 | $7 |
| Hydrochlorothiazide | 88 | $624 | $7 |
| Valsartan-Hydrochlorothiazide | 16 | $545 | $34 |
| Lovastatin | 35 | $461 | $13 |
| Propranolol | 19 | $405 | $21 |
| Furosemide | 118 | $394 | $3 |
| Spironolactone | 44 | $323 | $7 |
| Pantoprazole | 20 | $322 | $16 |
| Bumetanide | 15 | $279 | $19 |
| Bisoprolol | 11 | $255 | $23 |
| Digox | 11 | $254 | $23 |
| Labetalol | 13 | $235 | $18 |
| Metformin | 16 | $163 | $10 |
| Verapamil Er | 13 | $160 | $12 |
| Clonidine | 27 | $111 | $4 |
| Cephalexin | 12 | $94 | $8 |
| Triamterene-Hydrochlorothiazid | 13 | $83 | $6 |
2014: 60 drugs
| Xarelto | 308 | $116,444 | $378 |
| Ranexa | 239 | $82,429 | $345 |
| Pradaxa | 131 | $56,558 | $432 |
| Tikosyn | 180 | $55,979 | $311 |
| Crestor | 120 | $40,745 | $340 |
| Multaq | 64 | $27,830 | $435 |
| Bystolic | 102 | $20,744 | $203 |
| Metoprolol | 549 | $19,222 | $35 |
| Effient | 41 | $18,791 | $458 |
| Benicar | 67 | $17,819 | $266 |
| Lovaza | 55 | $15,676 | $285 |
| Eliquis | 40 | $15,287 | $382 |
| Niacin Er | 63 | $11,816 | $188 |
| Omega-3 Acid Ethyl Esters | 44 | $8,952 | $203 |
| Amiodarone | 171 | $8,367 | $49 |
| Clopidogrel | 473 | $8,315 | $18 |
| Diovan | 29 | $7,507 | $259 |
| Vytorin | 20 | $7,253 | $363 |
| Pravastatin | 269 | $6,761 | $25 |
| Atorvastatin | 376 | $6,651 | $18 |
| Plavix | 26 | $6,611 | $254 |
| Zetia | 20 | $5,278 | $264 |
| Sotalol | 181 | $4,394 | $24 |
| Simcor | 17 | $4,045 | $238 |
| Coreg Cr | 16 | $3,206 | $200 |
| Eplerenone | 37 | $2,723 | $74 |
| Losartan | 237 | $2,477 | $10 |
| Amlodipine Besylate | 382 | $2,380 | $6 |
| Fenofibrate | 24 | $2,352 | $98 |
| Warfarin | 162 | $2,152 | $13 |
| Propafenone | 73 | $1,975 | $27 |
| Azor | 12 | $1,804 | $150 |
| Flecainide Acetate | 70 | $1,723 | $25 |
| Ramipril | 48 | $1,662 | $35 |
| Isosorbide Mononitrate Er | 107 | $1,659 | $16 |
| Carvedilol | 156 | $1,562 | $10 |
| Simvastatin | 182 | $1,480 | $8 |
| Lisinopril | 137 | $1,108 | $8 |
| Nitrostat | 58 | $972 | $17 |
| Valsartan-Hydrochlorothiazide | 18 | $961 | $53 |
| Fenofibrate | 12 | $930 | $77 |
| Losartan-Hydrochlorothiazide | 80 | $858 | $11 |
| Fenofibrate | 19 | $848 | $45 |
| Atenolol | 113 | $808 | $7 |
| Propranolol Hcl Er | 18 | $694 | $39 |
| Lovastatin | 31 | $693 | $22 |
| Irbesartan | 27 | $677 | $25 |
| Potassium Chloride | 42 | $677 | $16 |
| Diltiazem Er | 17 | $634 | $37 |
| Metoprolol | 98 | $593 | $6 |
| Hydrochlorothiazide | 103 | $573 | $6 |
| Spironolactone | 67 | $474 | $7 |
| Furosemide | 120 | $405 | $3 |
| Bisoprolol | 14 | $359 | $26 |
| Labetalol | 12 | $261 | $22 |
| Enalapril Maleate | 20 | $240 | $12 |
| Pantoprazole | 12 | $210 | $17 |
| Clonidine | 26 | $197 | $8 |
| Propranolol | 16 | $157 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $112 | $7 |
2013: 61 drugs
| Ranexa | 198 | $63,471 | $321 |
| Tikosyn | 145 | $43,894 | $303 |
| Pradaxa | 94 | $36,825 | $392 |
| Xarelto | 106 | $36,079 | $340 |
| Clopidogrel | 579 | $32,896 | $57 |
| Crestor | 123 | $32,852 | $267 |
| Lovaza | 122 | $29,692 | $243 |
| Effient | 81 | $26,321 | $325 |
| Multaq | 56 | $22,146 | $395 |
| Metoprolol | 566 | $17,880 | $32 |
| Benicar | 82 | $16,206 | $198 |
| Bystolic | 111 | $13,279 | $120 |
| Diovan | 55 | $11,098 | $202 |
| Niaspan | 64 | $11,094 | $173 |
| Atorvastatin | 379 | $10,035 | $26 |
| Plavix | 36 | $8,794 | $244 |
| Vytorin | 25 | $5,592 | $224 |
| Sotalol | 179 | $4,648 | $26 |
| Pravastatin | 259 | $4,370 | $17 |
| Losartan | 291 | $3,961 | $14 |
| Eplerenone | 44 | $3,537 | $80 |
| Zetia | 16 | $3,196 | $200 |
| Coreg Cr | 16 | $3,125 | $195 |
| Fenofibrate | 23 | $2,999 | $130 |
| Amlodipine Besylate | 358 | $2,855 | $8 |
| Warfarin | 173 | $2,603 | $15 |
| Niacin Er | 15 | $2,205 | $147 |
| Simvastatin | 247 | $2,129 | $9 |
| Amiodarone | 177 | $1,990 | $11 |
| Simcor | 11 | $1,989 | $181 |
| Flecainide Acetate | 57 | $1,848 | $32 |
| Carvedilol | 157 | $1,735 | $11 |
| Azor | 12 | $1,587 | $132 |
| Losartan-Hydrochlorothiazide | 86 | $1,430 | $17 |
| Propafenone | 38 | $1,288 | $34 |
| Fenofibrate | 20 | $1,229 | $61 |
| Lisinopril | 121 | $1,148 | $9 |
| Isosorbide Mononitrate Er | 72 | $1,137 | $16 |
| Valsartan-Hydrochlorothiazide | 12 | $1,031 | $86 |
| Atenolol | 133 | $1,017 | $8 |
| Propranolol | 48 | $917 | $19 |
| Fenofibrate | 12 | $909 | $76 |
| Lovastatin | 42 | $877 | $21 |
| Ramipril | 48 | $845 | $18 |
| Potassium Chloride | 38 | $759 | $20 |
| Metoprolol | 120 | $755 | $6 |
| Nitrostat | 59 | $725 | $12 |
| Nitroglycerin Patch | 12 | $674 | $56 |
| Hydrochlorothiazide | 103 | $673 | $7 |
| Quinapril | 15 | $523 | $35 |
| Furosemide | 121 | $425 | $4 |
| Spironolactone | 45 | $393 | $9 |
| Pantoprazole | 27 | $384 | $14 |
| Bisoprolol | 24 | $366 | $15 |
| Triamterene-Hctz | 41 | $352 | $9 |
| Benazepril | 18 | $227 | $13 |
| Clonidine | 20 | $178 | $9 |
| Enalapril Maleate | 22 | $149 | $7 |
| Allopurinol | 20 | $81 | $4 |
| Niacor | 11 | $68 | $6 |
| Lisinopril-Hydrochlorothiazide | 19 | $64 | $3 |
Money from drug and device companies
$2,767 in 2025
| 2025 | 7 | 32 | None | $2,767 |
| 2024 | 6 | 34 | None | $4,323 |
| 2023 | 14 | 64 | None | $3,962 |
| 2022 | 10 | 46 | None | $4,080 |
| 2021 | 8 | 42 | None | $1,059 |
| 2020 | 9 | 25 | None | $391 |
| 2019 | 13 | 106 | None | $3,812 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Evera Mri Xt Dr Surescan | $1,546 | 7 payments
|
| Boston Scientific | Watchman Access System | $517 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $431 | 14 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $150 | 1 payment
|
| Pfizer | Eliquis | $79 | 5 payments
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $27 | 1 payment
|
See all 32 published payments
| Baxter Healthcare | Meals · 2025-11-25 | Hillrom - Cardiac Ambulatory Monitor | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-24 | Eliquis | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-07 | Kerendia | $150 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Eliquis | $20 |
| Pfizer | Meals · 2025-10-28 | Eliquis | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-27 | Eliquis | $15 |
| Medtronic | Meals · 2025-10-21 | None | $1 |
| Medtronic | Meals · 2025-10-21 | Evera Mri Xt Dr Surescan | $109 |
| Medtronic | Meals · 2025-10-20 | Aurora Ev-Icd Mri Surescan | $76 |
| Medtronic | Travel · 2025-10-20 | Evera Mri Xt Dr Surescan | $249 |
| Medtronic | Travel · 2025-10-20 | Evera Mri Xt Dr Surescan | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-14 | None | $132 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-06 | Camzyos | $123 |
| Medtronic | Travel · 2025-09-26 | Evera Mri Xt Dr Surescan | $914 |
| Merck Sharp & Dohme | Meals · 2025-08-12 | Verquvo | $17 |
| Pfizer | Meals · 2025-08-07 | Eliquis | $20 |
| Pfizer | Meals · 2025-07-30 | Eliquis | $17 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-28 | Eliquis | $13 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-08 | Eliquis | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-13 | Camzyos | $13 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-02 | Camzyos | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-21 | Eliquis | $11 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-08 | Eliquis | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-01 | Eliquis | $15 |
| Medtronic | Meals · 2025-03-27 | Aurora Ev-Icd Mri Surescan | $170 |
| Boston Scientific | Travel · 2025-03-20 | Watchman Access System | $87 |
| Boston Scientific | Travel · 2025-03-20 | Watchman Access System | $405 |
| Boston Scientific | Meals · 2025-03-20 | Watchman Access System | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-13 | Camzyos | $11 |
| Pfizer | Meals · 2025-02-24 | Eliquis | $14 |
| Pfizer | Meals · 2025-02-10 | Eliquis | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-16 | Camzyos | $13 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $4,323
| Biotronik | Selectra | $3,372 | 15 payments
|
| Boston Scientific | Watchman Access System | $656 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $223 | 10 payments
|
| Pfizer | Eliquis | $35 | 2 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $21 | 1 payment
|
| Abbott Laboratories | Gallant | $16 | 1 payment
|
2023: $3,962
| Biotronik | None | $1,763 | 3 payments
|
| Medtronic | Micra | $1,466 | 16 payments
|
| Pfizer | Eliquis | $198 | 20 payments
|
| Janssen Pharmaceuticals | Xarelto | $97 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $77 | 3 payments
|
| Amarin Pharma | Vascepa | $73 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $68 | 3 payments
|
| Boston Scientific | Watchman Flx | $64 | 3 payments
|
| Biosense Webster | Carto 3 | $40 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $34 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $25 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $13 | 1 payment
|
2022: $4,080
| Biotronik | Solia | $2,411 | 12 payments
|
| Boston Scientific | Watchman Access System | $959 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $211 | 8 payments
|
| Amarin Pharma | Vascepa | $137 | 11 payments
|
| Medtronic | Micra | $134 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $68 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $48 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $45 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $41 | 2 payments
|
| Philips Electronics North America | (5050) Ext Holter | $26 | 1 payment
|
2021: $1,059
| Boston Scientific | Watchman | $286 | 4 payments
|
| Amarin Pharma | Vascepa | $276 | 25 payments
|
| Philips Electronics North America | (8333) Igt D Coronary | $261 | 3 payments
|
| Biotronik | Pulsar | $79 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $65 | 3 payments
|
| Medtronic | Reveal Linq | $57 | 2 payments
|
| Amgen | Repatha | $24 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $12 | 1 payment
|
2020: $391
| Amarin Pharma | Vascepa | $165 | 14 payments
|
| Sanofi-Aventis U.S. | Multaq | $59 | 3 payments
|
| Amgen | Repatha | $30 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $29 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $27 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $26 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
| Akcea Therapeutics | Tegsedi | $15 | 1 payment
|
2019: $3,812
| Biotronik | None | $1,869 | 11 payments
|
| Amarin Pharma | Vascepa | $555 | 39 payments
|
| Akcea Therapeutics | Tegsedi | $389 | 4 payments
|
| Medical Device Business Services | Carto 3 System | $218 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $202 | 29 payments
|
| Janssen Pharmaceuticals | Xarelto | $181 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $167 | 4 payments
|
| Relypsa | Veltassa | $111 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $40 | 2 payments
|
| Pfizer | Eliquis | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $23 | 1 payment
|
| Amgen | Repatha | $21 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $12 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 916 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 100%That's most of the people this applied to. | 759 |
| Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 100% | 32 |
| Coronary Artery Disease (CAD): Antiplatelet TherapyAs Medicare defines this measure | 100% | 726 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 2,591 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,411 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1942368444
- Licence
- CA A53756California A53756: Current · expires 2028-02-29
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 105 N Bascom Ave, Suite 204, San Jose, CA, 95128
- NPI first listed
- 2006-12-05
- NPI last updated
- 2008-02-07
This is when the NPI record was last certified, not a medical board exam.